Betamethasone Valerate

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Betamethasone Valerate

Administration Routes

UnknownTopical

Species Affected

Unknown 11
Dog 1

Most Affected Breeds

Unknown 11
Pit Bull 1

Most Reported Reactions

Applicator, Abnormal 3
Administration device NOS, malfunction 3
Administration device NOS, damaged 2
Allergic pruritus 1
Erythematous rash 1
Hives (see also 'Skin') 1
Defect Unknown/Not Specified 1
Underfilling, Container 1
Dispenser, Abnormal 1
Stability failure 1

Outcome Breakdown

Recovered/Normal
1 (100.0%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 2
Distinct reactions reported 10
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Betamethasone Valerate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Betamethasone Valerate, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Betamethasone Valerate. Reported administration routes include Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Betamethasone Valerate reports are Unknown (11 reports), Dog (1 reports), with Unknown accounting for the largest share. Within those species, Unknown (11), Pit Bull (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Betamethasone Valerate are Applicator, Abnormal (3), Administration device NOS, malfunction (3), Administration device NOS, damaged (2), Allergic pruritus (1). Of the 1 reports with a coded outcome, Recovered/Normal is the leading category at 100.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Betamethasone Valerate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial